The Adipose-Tumor Signaling Network in Colorectal Cancer: Metabolic Reprogramming, Immune Escape, and Therapeutic Vulnerabilities
Keywords:
Colorectal cancer, Adipose tissue, Leptin, Tumor microenvironment, Metabolic reprogrammingAbstract
Background: Obesity is increasingly recognized as a biologically active modifier of colorectal cancer (CRC), yet body mass alone does not explain howadipose tissue influences tumor behavior. Dysfunctional visceral fat releases adipokines, cytokines, lipids, and stromal signals that may reshape malignantcell metabolism, angiogenesis, immune surveillance, and treatment response
Downloads
References
Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229-263.
Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011;11(2):8597.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
NonCommercial — You may not use the material for commercial purposes.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.


